| Current Price | $134.21 | Mkt Cap | $252.3B |
|---|---|---|---|
| Open | $142.20 | P/E Ratio | 19.15 |
| Prev. Close | $134.21 | Div. (Yield) | $5.64 (4.0%) |
| Daily Range | $134.09 - $142.33 | Volume | 15,358,992 |
| 52-Wk Range | $106.86 - $175.91 | Avg. Daily Vol. | 5,269,971 |
| Current Price | $134.21 | Mkt Cap | $252.3B |
|---|---|---|---|
| Open | $142.20 | P/E Ratio | 19.15 |
| Prev. Close | $134.21 | Div. (Yield) | $5.64 (4.0%) |
| Daily Range | $134.09 - $142.33 | Volume | 15,358,992 |
| 52-Wk Range | $106.86 - $175.91 | Avg. Daily Vol. | 5,269,971 |
The best Bull and Bear pitches based on recency and number of recommendations.
Good new drugs coming on line to replace the profits that came from Humira
This mega-cap has made a big run since Express Scripts's announcement that it will take AbbVie's hep C treatment in lieu of Gilead's. Also, an amazing preponderance of CAPS bulls favor this stock beating the market from here -- very interesting. For… More
Read the most recent pitches from players about ABBV.
Recs
CellBlock9
(74.21)
Submitted: 8/16/2022 9:51:10 PM :
Start Price:
$141.42
NYSE:ABBV Score:
+11.49
zk
Recs
1russianguy
(86.82)
Submitted: 6/29/2022 3:30:45 PM :
Start Price:
$76.80
NYSE:ABBV Score:
+52.86
Can thrive during recession.
Recs
TMFWordman5150
(44.36)
Submitted: 2/17/2022 12:04:57 PM :
Start Price:
$142.43
NYSE:ABBV Score:
+13.71
Earnings Growth; a solid dividend of $5.64 per share; and a Pharma manufact. market with a CAGR of 11.34% through 2028.
Find the members with the highest scoring picks in ABBV.
cooleyly (58.76) Score: +348.50
The Score Leader is the player with the highest score across all their picks in ABBV.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| armydave | 55.26 |
|
|
5Y | $22.85 | +493.40% | +144.90% | +348.50 | 0 Comment | |
| pirotta | < 20 | 1/10/2013 |
|
5Y | $22.85 | +493.40% | +144.90% | +348.50 | 0 Comment | |
| deliman723 | 66.68 | 1/10/2013 |
|
5Y | $22.85 | +493.40% | +144.90% | +348.50 | 0 Comment | |
| concealedweaponR | < 20 | 1/10/2013 |
|
5Y | $22.85 | +493.40% | +144.90% | +348.50 | 0 Comment | |
| drjohn432 | < 20 |
|
|
5Y | $22.85 | +493.40% | +144.90% | +348.50 | 0 Comment | |
|
valari25 | 99.55 |
|
|
5Y | $22.85 | +493.40% | +144.90% | +348.50 | 0 Comment |
|
|
GW1000 | 85.95 |
|
|
5Y | $22.85 | +493.40% | +144.90% | +348.50 | 0 Comment |
|
|
mattmmurphy | 72.34 | 1/10/2013 |
|
5Y | $22.85 | +493.40% | +144.90% | +348.50 | 0 Comment |
| cooleyly | 58.76 | 1/10/2013 |
|
5Y | $22.85 | +493.40% | +144.90% | +348.50 | 0 Comment | |
|
|
kinosternon | 98.65 | 1/9/2013 |
|
5Y | $22.95 | +490.70% | +146.03% | +344.67 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
